These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 8967027

  • 1. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J.
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of glucagon secretion.
    Young A.
    Adv Pharmacol; 2005 Aug; 52():151-71. PubMed ID: 16492545
    [Abstract] [Full Text] [Related]

  • 3. Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.
    Castillo MJ, Scheen AJ, Lefèbvre PJ.
    Diabete Metab; 1995 Feb; 21(1):3-25. PubMed ID: 7781840
    [Abstract] [Full Text] [Related]

  • 4. [Role of amylin in the pathogenesis of type II diabetes mellitus].
    Prager R, Ludvik B, Hartter E.
    Acta Med Austriaca; 1991 Feb; 18(3):61-2. PubMed ID: 1950379
    [Abstract] [Full Text] [Related]

  • 5. Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.
    Koopmans SJ, Radder JK, Krans HM, Barge RM.
    Neth J Med; 1992 Aug; 41(1-2):82-90. PubMed ID: 1407245
    [Abstract] [Full Text] [Related]

  • 6. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A.
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [Abstract] [Full Text] [Related]

  • 7. [Relation between levels of leptin, insulin and cortisol in persons with the 5H (X) syndrome].
    Hrnciar J, Okapcová J, Lepej J, Gábor D.
    Vnitr Lek; 1998 Feb; 44(2):68-75. PubMed ID: 9820079
    [Abstract] [Full Text] [Related]

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 9. [The mechanisms of insulin resistance].
    Holtz J.
    Klin Wochenschr; 1992 Jun; 69 Suppl 29():52-62. PubMed ID: 1535403
    [Abstract] [Full Text] [Related]

  • 10. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.
    Leighton B, Cooper GJ.
    Nature; 1988 Oct 13; 335(6191):632-5. PubMed ID: 3050530
    [Abstract] [Full Text] [Related]

  • 11. [Hyperinsulinism and the coronary syndrome].
    Hrnciar J.
    Vnitr Lek; 1992 Nov 13; 38(11):1056-65. PubMed ID: 1494868
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 13; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 13. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH.
    Endocrinol Metab Clin North Am; 1992 Jun 13; 21(2):329-50. PubMed ID: 1612069
    [Abstract] [Full Text] [Related]

  • 14. Beta-cell function and mass in type 2 diabetes.
    Larsen MO.
    Dan Med Bull; 2009 Aug 13; 56(3):153-64. PubMed ID: 19728971
    [Abstract] [Full Text] [Related]

  • 15. The role of amylin in the physiology of glycemic control.
    Scherbaum WA.
    Exp Clin Endocrinol Diabetes; 1998 Aug 13; 106(2):97-102. PubMed ID: 9628238
    [Abstract] [Full Text] [Related]

  • 16. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW, Lips CJ.
    Int J Biochem Cell Biol; 2006 Aug 13; 38(5-6):726-36. PubMed ID: 16459127
    [Abstract] [Full Text] [Related]

  • 17. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May 13; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 18. [Clinical manifestations of the insulin resistance syndrome. The hormonal-metabolic syndrome X, the 5H syndrome and their etiopathogenesis].
    Hrnciar J.
    Vnitr Lek; 1995 Feb 13; 41(2):92-8. PubMed ID: 7725646
    [Abstract] [Full Text] [Related]

  • 19. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH.
    Diabetologia; 2002 Jun 13; 45(6):813-22. PubMed ID: 12107725
    [Abstract] [Full Text] [Related]

  • 20. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V, Antić S.
    Clin Lab; 2004 Jun 13; 50(5-6):271-8. PubMed ID: 15209435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.